Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer

Filter
Konferenceabstrakt i tidsskrift
2019

Bevacizumab improves efficacy of trifluridine/tipiracil (TAS-102) in patients with chemorefractory metastatic colorectal cancer: a Danish randomized trial

Pfeiffer, P., Yilmaz, M., Moller, S., Zitnjak, D., Maltha, L., Krogh, M., Winther, S., Petersen, L., Hejlesen, F., Thomsen, K. & Qvortrup, C., 2019, I : Annals of Oncology. 30, Suppl. 4, s. iv130-iv131 2 s., mdz154.013.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Early response evaluation and CEA response in patients treated in a Danish randomized study comparing trifluridine/tipiracil (TAS-102) with or without bevazicumab in patients with chemorefractory metastatic colorectal cancer (mCRC)

Qvortrup, C., Yilmaz, M., Möller, S., Zitnjak, D., Maltha, L., Krogh, M., Petersen, L. N., Hejlesen, F., Winther, S. B., Thomsen, K. G. & Pfeiffer, P., 1 okt. 2019, I : Annals of Oncology. 30, Suppl. 5, s. v233-v233 617P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Everyday life with long-term chemotherapy induced peripheral neuropathy among patient in adjuvant treatment for colorectal cancer: A multi methods study

Jensen, M., Yilmaz, M. & Pedersen, B., 1 okt. 2019, I : Annals of Oncology. 30, Suppl. 5, s. v843 CN98.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Pre-treatment serum 25-hydroxyvitamin D levels and survival in a Danish cohort of patients with pancreatic cancer

Rasmussen, L. S., Yilmaz, M., Falkmer, U. G., Poulsen, L. O., Bojesen, S. E., Jensen, B. V., Johansen, A. Z., Chen, I. M., Hansen, C. P., Hasselby, J. P., Pfeiffer, P., Bjerregaard, J. K., Nielsen, S. E., Andersen, F. Z., Hollander, N. H., Bogsted, M. & Johansen, J. S., 1 okt. 2019, I : Annals of Oncology. 30, Suppl. 5, 699P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Randomised trial of cetuximab every 2 weeks with FOLFIRI or cetuximab with alternating FOLFIRI/FOLFOX in patients with RAS and BRAF wild type metastatic colorectal cancer: Nordic 8 results

Pfeiffer, P., Glimelius, B., Winther, S., Qvortrup, C., Yilmaz, M., Berglund, A., Vistisen, K., Kersten, C., Liposits, G. & Sorbye, H., 2019, I : Annals of Oncology. 30, Suppl. 4, s. iv131-iv131 1 s., mdz154.014.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

7 Citationer (Scopus)
2018

Clinical utility of plasma cell-free DNA in patients with pancreatic cancer

Chen, I., Wind, K. L., Dehlendorff, C., Sørensen, B. S., Vittrup, B. V., Johansen, A., Pfeiffer, P., Bjerregaard, J. K., Bojesen, S. E., Nielsen, S. E., Holländer, N. H., Yilmaz, M. K., Rasmussen, L. S., Pallisgaard, N., Johansen, J. S. & Spindler, K-L. G., okt. 2018, I : Annals of Oncology. 29, suppl_8, s. vii241-vii242 2 s., 715P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

3 Citationer (Scopus)

Clinical utility of serum type III collagen in patients with pancreatic carcinoma

Chen, I., Willumsen, N., Dehlendorff, C., Johansen, A., Vittrup, B. V., Krüger, M., Pfeiffer, P., Bjerregaard, J. K., Bojesen, S. E., Nielsen, S. E., Holländer, N. H., Yilmaz, M. K., Rasmussen, L. S., Karsdal, M. & Johansen, J. S., okt. 2018, I : Annals of Oncology. 29, Suppl. 8, s. viii257 1 s., 752P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

6 Citationer (Scopus)

Initial treatment and survival in a national unselected Danish cohort of 4161 patients with pancreatic cancer

Rasmussen, L. S., Vittrup, B., Ladekarl, M., Pfeiffer, P., Yilmaz, M. K., Poulsen, L. Ø., Østerlind, K., Skuladottir, H., Hansen, C. P., Mortensen, M. B., Mortensen, F. V., Sall, M., Falkmer, U. G. & Fristrup, C., okt. 2018, I : Annals of Oncology. 29, Suppl. 8, s. 253-254 2 s., 743P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)

Winther, S. B., Skuladottir, H., Hofsli, E., Shah, C-H., Yilmaz, M. K., Österlund, P. J., Berglund, Å., Glimelius, B., Qvortrup, C., Sorbye, H. & Pfeiffer, P., okt. 2018, I : Annals of Oncology. 29, Suppl. 8, s. viii151 1 s., 455PD.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

2016

Is the accuracy of preoperative MRI stage in rectal carcinoma influenced by tumor height?

Poulsen, L. Ø., Yilmaz, M. K., Oddershede, L., Bøgsted, M., Holt, G., Eld, M., Ljungmann, K. & Falkmer, U. G. I., 2016, I : Journal of Clinical Oncology. 34, 4 Suppl., 514.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan

Jensen, B. V., Spindler, K-L. G., Christensen, I. J., Schou, JV., Nielsen, D. L., Jakobsen, A., Hogdall, E., Pfeiffer, P., Yilmaz, M. K. & Johansen, J., 2016, I : Annals of Oncology. 27, Suppl. 6, 95P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Prognostic mRNA expression signatures in whole blood in patients with metastatic colorectal cancer treated with 3rd line cetuximab and irinotecan

Schou, J. V., Jensen, B. V., Nielsen, D. L., Palshof, J. A., Hogdall, E., Yilmaz, M. K., Pfeiffer, P., Johansen, J. & Rossi, S., 2016, I : Annals of Oncology. 27, Suppl. 6, 574P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Risk factors for brain metastases in patients with metastatic colorectal cancer

Christensen, T. D., Palshof, J. A., Larsen, F. O., Hogdall, E., Poulsen, T. S., Jensen, B. V., Pfeiffer, P., Yilmaz, M. K., Christensen, I. J. & Nielsen, D. L., 2016, I : Annals of Oncology. 27, Suppl. 6, 580P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Serum interleukin-6 as a prognostic biomarker for survival in patients with unresectable pancreatic cancer

Chen, I., Dehlendorff, C., Jensen, B. V., Pfeiffer, P., Nielsen, S. E., Hollander, N. H., Yilmaz, M. K. & Johansen, J., 2016, I : Annals of Oncology. 27, Suppl. 6, 86P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

The CAIRO4 study: The role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer - a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)

de Wilt, J. H. W., Verhoef, C., Punt, C. J. A., 't Lam-Boer, J., Yilmaz, M., Mol, L. & Koopman, M., 2016, I : Journal of Clinical Oncology. 34, 4 Suppl., TPS782.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

The role of risk factors on survival for patients with pancreatic cancer

Bagni, R. K., Dehlendorff, C., Jensen, B. V., Johansen, A. Z., Pfeiffer, P., Hansen, C. P., Nielsen, S. E., Yilmaz, M. K., Hollander, N. H. & Johansen, J., 2016, I : Annals of Oncology. 27, Suppl. 6, 689P.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Total cell-free DNA level in plasma as strong prognostic marker in metastatic colorectal cancer

Spindler, K-L., Demuth, C., Sørensen, B., Johansen, J., Nielsen, D., Pallisgaard, N., Høgdall, E., Pfeiffer, P., Yilmaz, M. & Jensen, B., 2016, I : Annals of Oncology. 27, Suppl. 2, s. 102 PD-001.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Åben adgang
2015

DYPD genotyping to predict toxicity in patients with stage III colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy in the PETACC-8 phase III trial

Boige, V., Vincent, M., Alexandre, P., Stoehlmacher, J., Tejpar, S., Landolfi, S., Le Malicot, K., Greil, R., Cuyle, P-J. AR., Yilmaz, M. K., Faroux, R., Matzdorff, A., Salazar, R., Sanches, E., Mineur, L., Lepage, C., Taïeb, J. & Laurent-Puig, P., 2015, I : Journal of Clinical Oncology. 33, 15 Suppl., TPS3584.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

The CAIRO4 study: The role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer-a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)

't Lam-Boer, J., Mol, L., Verhoef, C., de Haan, A. F. J., Yilmaz, M., Punt, C. J. A., de Wilt, J. H. W. & Koopman, M., 2015, I : Journal of Clinical Oncology. 33, 15 Suppl., TPS3630.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Trastuzumab with triple chemotherapy (DOC-T) in patients with advanced gastro-esophageal cancer: A phase I/II study

Pfeiffer, P., Yilmaz, M. K., Bæksgaard, L., Schønnemann, K. R., Krogh, M., Qvortrup, C., Bjerregaard, J. K., Jensen, H. A. & Weber Vestermark, L., 2015, I : European Journal of Cancer. 51, Sippl. 3, s. S450-S451 2348.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

2 Citationer (Scopus)
2014

Trastuzumab with triple chemotherapy (DOC) in patients with advanced gastroesophageal cancer: A phase I dose-finding trial

Schoennemann, K. R., Yilmaz, M. K., Baeksgaard, L., Jensen, H. A., Vestermark, L. W., Hansen, T. P. & Pfeiffer, P., 2014, I : Journal of Clinical Oncology. 32, 3_Suppl, 108.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

2010

Venous thromboembolism in patients receiving preoperative chemotherapy for gastric cancer

Larsen, A. C., Sunesen, K., Dabrowski, T., Fisker, R. V., Yilmaz, M. K. & Thorlacius-Ussing, O., apr. 2010, I : Thrombosis Research. 125, s. S169 1 s.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskning